|
Abgenix announces stockholder approval of acquisition by Amgen
March 29, 2006
Allon Begins Dosing First Patient for AL-208 Phase Ib Clinical Trial
March 27, 2006
Allon Reports 2005 Audited Operating Results
March 29, 2006
Angiotech announces license agreement between Surgical Specialties Corporation and Collagen Matrix Technologies Inc.
March 29, 2006
Angiotech Pharmaceuticals Closes Acquisition of American Medical Instruments Holdings, Inc.
March 23, 2006
AnorMED announces special shareholder meeting to be held on April 21, 2006
March 17, 2006
Anormed Releases Statement Regarding Rejection of the Baker Group Proposal & Decision to Hold Special Shareholder Meeting
March 20, 2006
Anormed Recommends Shareholders Reject Dissident Slate of Director Nominees
March 27, 2006
AnorMED to present at the CIBC World Markets Healthcare Conference
March 31, 2006
BC Biotech announces the appointment of Mr. Don Avison, President of the University Presidents’ Council of British Columbia to its Board of Directors
April 4, 2006
Chromos releases fiscal 2005 results
April 3, 2006
Forbes Medi-Tech Announces Change in Board of Directors
March 31, 2006
Forbes Provides 2006 Outlook for Sales, Including Reducol™ ~Company Achieves 2005 Revenue Guidance and Forecasts Strong Growth in Reducol™ Sales~
March 23, 2006
Forbes Medi-Tech Announces Timing of Year End Financial Results
March 29, 2006
Forbes Medi-Tech announces Financial Results for the Year ended 12/31/05 ~FY2005 Revenue up 19%; Increased R&D Activity Supports FM-VP4 Development~
March 30, 2006
GenoLogics, Institute for Systems Biology Announce Integration of the Trans Proteomic Pipeline with Proteus
March 21, 2006
Inex Pharmaceuticals Licenses Three Targeted Chemotherapy Products to Hana Biosciences
March 17, 2006
INEX and Alnylam Announce Research Collaboration for Systemic Delivery of RNAi Therapeutics
March 27, 2006
INEX Receives Notice from Protiva Biotherapeutics
March 29, 2006
INEX Releases 2005 Operating Results
March 30, 2006
Ondine Biopharma Receives CE Mark Approval for PERIOWAVE
March 30, 2006
Perceptronix Announces The Opening Of Its First Clinial Quantitative Cytology Lab
March 30, 2006
Perceptronix Receives US Food and Drug Administration Medical Device Listing And CE Mark For CLEAR2C™
April 4, 2006
Protox Therapeutics to Present at Invest Northwest Conference
March 16, 2006
Protox Therapeutics to be featured on CEO Clips on The Biography Channel
March 27, 2006
Protox Therapeutics Announces Presentation of Data at Leading Cancer Research Conference
April 3, 2006
QSV Biologics, Ltd. Signs Supply Contract with Tissue Therapies, Ltd. for Manufacturing VitroGro® Components
March 31, 2006
Stressgen obtains securityholder approval for corporate transaction
March 16, 2006
Stressgen Biotechnologies Announces 2005 Financial Results
March 22, 2006
Stressgen Completes Corporate Transaction
March 24, 2006
|
